Highlights and summary of the 28th annual meeting of the Society for Immunotherapy of Cancer

Paolo A. Ascierto, David H Munn, Anna K. Palucka, Paul M. Sondel

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

The 28th annual meeting of the Society for Immunotherapy of Cancer (SITC) was held November 8-10, 2013 in National Harbor MD, and was organized by Paolo Ascierto (Instituto Nazionale Tumori - Fondazione 'G. Pascale'), David Munn (Georgia Regent's University), A. Karolina Palucka (Baylor Institute for Immunology Research) and Paul Sondel (University of Wisconsin). This meeting included over 1100 registered participants from 32 separate countries, making it the largest SITC meeting held to date. It highlighted significant worldwide progress in the development and application of cancer immunology to the practice of clinical oncology, including advances in diagnosis, prognosis and therapy, utilizing a variety of immunological pathways and mechanisms for a variety of oncologic conditions. Presentations and posters demonstrated that many concepts that had been pursued preclinically in the past are now being translated into clinical practice, with clear benefits for patients. One month after this 28th annual meeting, the Journal Science selected the field of Cancer Immunotherapy as the overall #1 scientific " breakthrough" for 2013.

Original languageEnglish (US)
Article number15
JournalJournal for ImmunoTherapy of Cancer
Volume2
Issue number1
DOIs
StatePublished - May 15 2014

Fingerprint

Immunotherapy
Allergy and Immunology
Neoplasms
Posters
Medical Oncology
Therapeutics

Keywords

  • Adaptive immunity
  • Adoptive immunotherapy
  • Cancer
  • Immune escape
  • Immunotherapy
  • Innate immunity

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Cite this

Highlights and summary of the 28th annual meeting of the Society for Immunotherapy of Cancer. / Ascierto, Paolo A.; Munn, David H; Palucka, Anna K.; Sondel, Paul M.

In: Journal for ImmunoTherapy of Cancer, Vol. 2, No. 1, 15, 15.05.2014.

Research output: Contribution to journalReview article

@article{c00501b1dc144273853862bbbf5f3168,
title = "Highlights and summary of the 28th annual meeting of the Society for Immunotherapy of Cancer",
abstract = "The 28th annual meeting of the Society for Immunotherapy of Cancer (SITC) was held November 8-10, 2013 in National Harbor MD, and was organized by Paolo Ascierto (Instituto Nazionale Tumori - Fondazione 'G. Pascale'), David Munn (Georgia Regent's University), A. Karolina Palucka (Baylor Institute for Immunology Research) and Paul Sondel (University of Wisconsin). This meeting included over 1100 registered participants from 32 separate countries, making it the largest SITC meeting held to date. It highlighted significant worldwide progress in the development and application of cancer immunology to the practice of clinical oncology, including advances in diagnosis, prognosis and therapy, utilizing a variety of immunological pathways and mechanisms for a variety of oncologic conditions. Presentations and posters demonstrated that many concepts that had been pursued preclinically in the past are now being translated into clinical practice, with clear benefits for patients. One month after this 28th annual meeting, the Journal Science selected the field of Cancer Immunotherapy as the overall #1 scientific {"} breakthrough{"} for 2013.",
keywords = "Adaptive immunity, Adoptive immunotherapy, Cancer, Immune escape, Immunotherapy, Innate immunity",
author = "Ascierto, {Paolo A.} and Munn, {David H} and Palucka, {Anna K.} and Sondel, {Paul M.}",
year = "2014",
month = "5",
day = "15",
doi = "10.1186/2051-1426-2-15",
language = "English (US)",
volume = "2",
journal = "Journal for ImmunoTherapy of Cancer",
issn = "2051-1426",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Highlights and summary of the 28th annual meeting of the Society for Immunotherapy of Cancer

AU - Ascierto, Paolo A.

AU - Munn, David H

AU - Palucka, Anna K.

AU - Sondel, Paul M.

PY - 2014/5/15

Y1 - 2014/5/15

N2 - The 28th annual meeting of the Society for Immunotherapy of Cancer (SITC) was held November 8-10, 2013 in National Harbor MD, and was organized by Paolo Ascierto (Instituto Nazionale Tumori - Fondazione 'G. Pascale'), David Munn (Georgia Regent's University), A. Karolina Palucka (Baylor Institute for Immunology Research) and Paul Sondel (University of Wisconsin). This meeting included over 1100 registered participants from 32 separate countries, making it the largest SITC meeting held to date. It highlighted significant worldwide progress in the development and application of cancer immunology to the practice of clinical oncology, including advances in diagnosis, prognosis and therapy, utilizing a variety of immunological pathways and mechanisms for a variety of oncologic conditions. Presentations and posters demonstrated that many concepts that had been pursued preclinically in the past are now being translated into clinical practice, with clear benefits for patients. One month after this 28th annual meeting, the Journal Science selected the field of Cancer Immunotherapy as the overall #1 scientific " breakthrough" for 2013.

AB - The 28th annual meeting of the Society for Immunotherapy of Cancer (SITC) was held November 8-10, 2013 in National Harbor MD, and was organized by Paolo Ascierto (Instituto Nazionale Tumori - Fondazione 'G. Pascale'), David Munn (Georgia Regent's University), A. Karolina Palucka (Baylor Institute for Immunology Research) and Paul Sondel (University of Wisconsin). This meeting included over 1100 registered participants from 32 separate countries, making it the largest SITC meeting held to date. It highlighted significant worldwide progress in the development and application of cancer immunology to the practice of clinical oncology, including advances in diagnosis, prognosis and therapy, utilizing a variety of immunological pathways and mechanisms for a variety of oncologic conditions. Presentations and posters demonstrated that many concepts that had been pursued preclinically in the past are now being translated into clinical practice, with clear benefits for patients. One month after this 28th annual meeting, the Journal Science selected the field of Cancer Immunotherapy as the overall #1 scientific " breakthrough" for 2013.

KW - Adaptive immunity

KW - Adoptive immunotherapy

KW - Cancer

KW - Immune escape

KW - Immunotherapy

KW - Innate immunity

UR - http://www.scopus.com/inward/record.url?scp=84977107124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977107124&partnerID=8YFLogxK

U2 - 10.1186/2051-1426-2-15

DO - 10.1186/2051-1426-2-15

M3 - Review article

AN - SCOPUS:84977107124

VL - 2

JO - Journal for ImmunoTherapy of Cancer

JF - Journal for ImmunoTherapy of Cancer

SN - 2051-1426

IS - 1

M1 - 15

ER -